DRA Uges
Impact in
-
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
-
- Chemotherapy-induced organ toxicity mitigation
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 5
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- NH Mulder (5 shared papers)Coby Meijer (3 shared papers)Jourik A. Gietema (3 shared papers)Dirk Th. Sleijfer (3 shared papers)J�rgen Messerschmidt (1 shared paper)Friedrich Alt (1 shared paper)Phb Willemse (3 shared papers)Harm H. Kampinga (1 shared paper)
- Journals
- British Journal of Cancer (6 papers)The Lancet (3 papers)Pediatric Research (1 paper)PubMed (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
DRA Uges
11 papers receiving 456 citations
Peers
Comparison fields: 5 of 72
- Oncology 164
- Pathology and Forensic Medicine 77
- Reproductive Medicine 35
- Biochemistry 22
- Chemical Health and Safety 2
Countries citing papers authored by DRA Uges
This map shows the geographic impact of DRA Uges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DRA Uges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DRA Uges more than expected).
Fields of papers citing papers by DRA Uges
This network shows the impact of papers produced by DRA Uges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DRA Uges. The network helps show where DRA Uges may publish in the future.
Co-authors
The 21 scholars most cited alongside DRA Uges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 170 | |
| 2 | 1990 | 112 | |
| 3 | 1995 | 50 | |
| 4 | 1997 | 49 | |
| 5 | 1995 | 47 | |
| 6 | 1997 | 23 | |
| 7 | 1990 | 18 | |
| 8 | UNITS FOR THERAPEUTIC DRUG-MONITORING TOXICOLOGY | 1986 | 8 |
| 9 | 1998 | 3 | |
| 10 | Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4. | 1987 | 2 |
| 11 | Morphine profiles during ECMO, the effect of concomitant medication | 2002 | 1 |
About DRA Uges
DRA Uges is a scholar working on Pathology and Forensic Medicine, Oncology, Emergency Medicine, Physical and Theoretical Chemistry and Genetics, having authored 11 papers that have together received 483 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers), Mast cells and histamine (1 paper), Ferrocene Chemistry and Applications (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper) and Muscle and Compartmental Disorders (1 paper). The work is most often cited by research in Oncology (164 citations), Pathology and Forensic Medicine (77 citations), Reproductive Medicine (35 citations), Biochemistry (22 citations) and Chemical Health and Safety (2 citations). DRA Uges has collaborated with scholars based in Netherlands and United States. Frequent co-authors include NH Mulder, Coby Meijer, Jourik A. Gietema, Dirk Th. Sleijfer, J�rgen Messerschmidt, Friedrich Alt, Phb Willemse, Harm H. Kampinga, W.J. Sluiter and Hetty Timmer‐Bosscha. Their work appears in journals such as British Journal of Cancer, The Lancet, Pediatric Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.